These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35101641)

  • 1. Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options.
    Nakhjavani M; Samarasinghe RM; Shigdar S
    Drug Discov Today; 2022 May; 27(5):1298-1314. PubMed ID: 35101641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages.
    Zhang T; Lip H; He C; Cai P; Wang Z; Henderson JT; Rauth AM; Wu XY
    Adv Healthc Mater; 2019 Sep; 8(18):e1900543. PubMed ID: 31348614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple Negative Breast Cancer and Brain Metastases.
    Bansal R; Van Swearingen AED; Anders CK
    Clin Breast Cancer; 2023 Dec; 23(8):825-831. PubMed ID: 37586926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets.
    Lv Y; Ma X; Du Y; Feng J
    Onco Targets Ther; 2021; 14():589-607. PubMed ID: 33519208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
    Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
    Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.
    Siddappa CM; Pillai SG; Snider J; Alldredge P; Trinkaus K; Watson MA; Aft R
    Breast Cancer Res Treat; 2019 Nov; 178(2):317-325. PubMed ID: 31432366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.
    Wan X; Zheng X; Pang X; Pang Z; Zhao J; Zhang Z; Jiang T; Xu W; Zhang Q; Jiang X
    Oncotarget; 2016 Jun; 7(23):34038-51. PubMed ID: 27086917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?
    Bai X; Ni J; Beretov J; Graham P; Li Y
    Cancer Lett; 2021 Jan; 497():100-111. PubMed ID: 33069769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer.
    Nakhjavani M; Hardingham JE; Palethorpe HM; Price TJ; Townsend AR
    J Breast Cancer; 2019 Sep; 22(3):341-361. PubMed ID: 31598336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer.
    Kumari M; Krishnamurthy PT; Sola P
    Curr Cancer Drug Targets; 2020; 20(8):559-572. PubMed ID: 32370716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer.
    Liu S; Li J; Gu L; Wu K; Xing H
    Int J Nanomedicine; 2022; 17():5209-5227. PubMed ID: 36388877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.
    Gabani P; Weiner AA; Hernandez-Aya LF; Khwaja S; Roach MC; Ochoa LL; Mullen D; Thomas MA; Matesa MA; Margenthaler JA; Cyr AE; Naughton MJ; Ma C; Sanati S; Zoberi I
    Breast J; 2019 May; 25(3):363-372. PubMed ID: 30920124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosoldiers: A promising strategy to combat triple negative breast cancer.
    Pawar A; Prabhu P
    Biomed Pharmacother; 2019 Feb; 110():319-341. PubMed ID: 30529766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the discovery of drugs for triple-negative breast cancer metastasis.
    Altei WF; Pachane BC; Souza C; Marques MMC; Selistre-de-Araújo H
    Expert Opin Drug Discov; 2022 Apr; 17(4):365-376. PubMed ID: 35179448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.
    Duchnowska R; Jarząb M; Żebracka-Gala J; Matkowski R; Kowalczyk A; Radecka B; Kowalska M; Pfeifer A; Foszczyńska-Kłoda M; Musolino A; Czartoryska-Arłukowicz B; Litwiniuk M; Surus-Hyla A; Szabłowska-Siwik S; Karczmarek-Borowska B; Dębska-Szmich S; Głodek-Sutek B; Sosińska-Mielcarek K; Chmielowska E; Kalinka-Warzocha E; Olszewski WP; Patera J; Żawrocki A; Pliszka A; Tyszkiewicz T; Rusinek D; Oczko-Wojciechowska M; Jassem J; Biernat W;
    Clin Breast Cancer; 2017 Apr; 17(2):e65-e75. PubMed ID: 27692773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer.
    He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY
    J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-stage targeted therapy for the brain metastasis from triple-negative breast cancer.
    Luo Z; Wu S; Zhou J; Xu W; Xu Q; Lu L; Xie C; Liu Y; Lu W
    Acta Pharm Sin B; 2023 Jan; 13(1):359-371. PubMed ID: 36815053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.